Cancer Genetics Launches Proprietary Microarray for Kidney Cancer
The company has received regulatory approvals from both CLIA and New York State and will offer the genomic microarray as part of its Kidney Complete Program.
Read More
Search Results for: genetic testing
Roundtable Discussion: Cardiovascular Testing Products
Subject matter experts discuss their company’s offerings.
Read More
From the Editor: May 2013: Yes, Billion
Another consolidation in the works, and lab professionals share their hard-won experience face to face.
Read More
Myriad Adopts RainDance’s ThunderStorm Platform for NGS-Based Hereditary Cancer Panel
Myriad will have the ability to detect large gene rearrangements, while at the same time gaining workflow benefits, and a favorable cost profile.
Read More
Thermo Fisher Scientific to Acquire Life Technologies for $13.6 Billion
The new synergy is expected to create opportunities to support the convergence of life sciences tools and diagnostics–helping pave the way for greater adoption of personalized medicine.
Read More